Recombinant EGF, Rat (CHO-expressed) 
Source: CHO
Molecular Weight: ~6 kDa, observed by reducing SDS-PAGE.

Recombinant Epigen, Human(CHO-expressed) 
Source: CHO
Molecular Weight: 15~20 kDa, observed by reducing SDS-PAGE.

Recombinant Epigen, Human(CHO-expressed) 
Source: CHO
Molecular Weight: 15~20 kDa, observed by reducing SDS-PAGE.

Recombinant EPO, Human 
Source: CHO
Molecular Weight: Mature human EPO, containing 166 amino acid residues, has a predicted molecular mass of approximately 21 kDa. As a result of glycosylation, the recombinant protein migrates with an apparent molecular mass of 26-36 kDa in SDS-PAGE.

Recombinant EPO, Human 
Source: CHO
Molecular Weight: Mature human EPO, containing 166 amino acid residues, has a predicted molecular mass of approximately 21 kDa. As a result of glycosylation, the recombinant protein migrates with an apparent molecular mass of 26-36 kDa in SDS-PAGE.

Recombinant EPO, Human 
Source: CHO
Molecular Weight: Mature human EPO, containing 166 amino acid residues, has a predicted molecular mass of approximately 21 kDa. As a result of glycosylation, the recombinant protein migrates with an apparent molecular mass of 26-36 kDa in SDS-PAGE.

Recombinant FGF-16, Human 
Source: CHO
Molecular Weight: 23 kDa, observed by reducing SDS-PAGE.

Recombinant FGF-16, Human 
Source: CHO
Molecular Weight: 23 kDa, observed by reducing SDS-PAGE.

Recombinant FGF-16, Human 
Source: CHO
Molecular Weight: 23 kDa, observed by reducing SDS-PAGE.

Recombinant FGF-21, His, Human 
Source: CHO
Molecular Weight: 23-25kDa, observed by reducing SDS-PAGE.

Recombinant FGF-21, His, Human 
Source: CHO
Molecular Weight: 23-25kDa, observed by reducing SDS-PAGE.

Recombinant FGF-21, His, Human 
Source: CHO
Molecular Weight: 23-25kDa, observed by reducing SDS-PAGE.